Vertex Pharmaceuticals Inc (VRTX)
411.09
+3.28
(+0.80%)
USD |
NASDAQ |
Mar 18, 16:00
411.09
0.00 (0.00%)
After-Hours: 20:00
Vertex Pharmaceuticals Price to Book Value: 6.040 for March 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 15, 2024 | 5.992 |
March 14, 2024 | 6.006 |
March 13, 2024 | 6.071 |
March 12, 2024 | 6.060 |
March 11, 2024 | 6.090 |
March 08, 2024 | 6.077 |
March 07, 2024 | 6.032 |
March 06, 2024 | 6.051 |
March 05, 2024 | 6.104 |
March 04, 2024 | 6.230 |
March 01, 2024 | 6.358 |
February 29, 2024 | 6.182 |
February 28, 2024 | 6.273 |
February 27, 2024 | 6.332 |
February 26, 2024 | 6.369 |
February 23, 2024 | 6.320 |
February 22, 2024 | 6.271 |
February 21, 2024 | 6.166 |
February 20, 2024 | 6.180 |
February 16, 2024 | 6.203 |
February 15, 2024 | 6.264 |
February 14, 2024 | 6.140 |
February 13, 2024 | 6.113 |
February 12, 2024 | 6.149 |
February 09, 2024 | 6.214 |
Date | Value |
---|---|
February 08, 2024 | 6.201 |
February 07, 2024 | 6.143 |
February 06, 2024 | 6.100 |
February 05, 2024 | 6.287 |
February 02, 2024 | 6.225 |
February 01, 2024 | 6.360 |
January 31, 2024 | 6.352 |
January 30, 2024 | 6.539 |
January 29, 2024 | 6.388 |
January 26, 2024 | 6.306 |
January 25, 2024 | 6.302 |
January 24, 2024 | 6.267 |
January 23, 2024 | 6.445 |
January 22, 2024 | 6.451 |
January 19, 2024 | 6.377 |
January 18, 2024 | 6.347 |
January 17, 2024 | 6.358 |
January 16, 2024 | 6.413 |
January 12, 2024 | 6.353 |
January 11, 2024 | 6.304 |
January 10, 2024 | 6.212 |
January 09, 2024 | 6.171 |
January 08, 2024 | 6.144 |
January 05, 2024 | 6.105 |
January 04, 2024 | 6.10 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.758
Minimum
Oct 05 2021
11.87
Maximum
Jun 23 2020
7.181
Average
6.257
Median
Dec 05 2022
Price to Book Value Benchmarks
Amgen Inc | 23.29 |
Eli Lilly and Co | 67.27 |
Regeneron Pharmaceuticals Inc | 4.059 |
Moderna Inc | 2.876 |
Pfizer Inc | 1.760 |
Price to Book Value Related Metrics
PE Ratio | 29.60 |
PS Ratio | 10.85 |
PEG Ratio | 3.582 |
Price to Free Cash Flow | 32.66 |
Price | 411.09 |
Earnings Yield | 3.38% |
Market Cap | 106.19B |
PEGY Ratio | 3.582 |
Operating PE Ratio | 24.86 |
Normalized PE Ratio | 26.80 |